Tech Company Financing Transactions
Paradigm Therapeutics Funding Round
Paradigm Therapeutics, based in Mt. Pleasant, scored $12.5 million in funding from Eshelman Ventures.
Transaction Overview
Company Name
Announced On
5/6/2025
Transaction Type
Venture Equity
Amount
$12,500,000
Round
Undisclosed
Investors
Proceeds Purpose
Funds will be used to complete all activities to support an NDA submission in the later part of 2025.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
465 West Coleman Blvd. 202
Mt. Pleasant, SC 29464
USA
Mt. Pleasant, SC 29464
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Paradigm Therapeutics is a biopharmaceutical company focused on developing innovative therapies for treating diseases with high unmet need, including orphan products. Paradigm Therapeutics is dedicated to developing innovative therapies for people living with rare diseases, including Epidermolysis Bullosa (EB).
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Robert Ryan
Browse more venture capital transactions:
Prev: 5/6/2025: Rentana venture capital transaction
Next: 5/6/2025: MyVenue venture capital transaction
Share this article
About Database of VC Transactions
We do our best to document every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs